The Effects of Glucagon on Hepatic Metabolism
Phase 1/2Completed
14 Nov 1960Discontinued
22 Jun 1998Discontinued
11 Sep 1998Discontinued
8 May 2015Diabetes, Severe Hypoglycemia
24 Jul 2019Diabetes, Severe Hypoglycemia
FDA Gvoke KIT, Gvoke Hypopen, Gvoke PFS, Gvoke Vialdx
10 Sep 2019Diabetes, Severe Hypoglycemia
16 Dec 2019Diabetes Mellitus, hypoglycaemia
11 Feb 2021Diabetes Mellitus, hypoglycaemia
Phase 4Completed8 trials
Phase 4Completed6 trials
Phase 4Results posted7 trials
Phase 4Results posted21 trials
Phase 3Completed1 trial
Phase 3Results posted19 trials
Phase 4Status unknown1 trial
Phase 4Completed1 trial
Phase 2Completed1 trial
Phase 2Results posted2 trials
Phase 1Completed1 trial
Non-alcoholic fatty liver disease
Phase 1/2Results posted2 trials
Phase 1Completed1 trial
Phase 1/2Results posted1 trial
Phase 1Completed1 trial
Phase 1Completed2 trials
Phase 1Results posted1 trial
Poisoning
Phase 4Completed1 trial
Congenital Hyperinsulinism
Phase 2Results posted2 trials
Company3 trialsPhase 270 people
Company1 trialPhase 144 people
Company1 trialPhase 142 people
Company1 trialPhase 138 people
Company1 trialPhase 118 people
Company1 trialPhase 18 people
Company1 trialEarly phase 115 people
National Taiwan University Hospital
1 trialPhase 4100 people
National Institute of Diabetes and Digestive and Kidney DiseasesUS$2.3mNational Institute on AgingUS$2.1mJapan Society for the Promotion of ScienceJP¥9.5m
National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of Texas Hlth Science CenterUS$40.3k2025–2030
Glucagon Like Peptide-1 Medicine Outcomes in Real World Patients with Type 1 Diabetes
National Institute of Diabetes and Digestive and Kidney DiseasesAdventhealth OrlandoUS$151.8k2026–2028
Glucagon secretion and action in humans
National Institute of Diabetes and Digestive and Kidney DiseasesMayo Clinic RochesterUS$520.5k2017–2027
Investigating the Role of Hepatic Glucagon Receptor Signaling in Healthspan and Aging
National Institute on AgingUniversity of ArizonaUS$603.7k2024–2029
Serum markers of glucagon sensitivity in calorie restricted humans
National Institute on AgingUniversity of ArizonaUS$426k2024–2026
Investigating the Role of Hepatic Glucagon Receptor Signaling in Healthspan and Aging
National Institute on AgingUniversity of ArizonaUS$316.2k2024
Role of glucagon in renal proximal tubule glycogenesis
Japan Society for the Promotion of ScienceUniversity of TokyoJP¥4.7m2021–2024
Instituto de Salud Carlos III2019–2021
Variations in plasma glucagon and incretin levels according to westernization of lifestyle
Japan Society for the Promotion of ScienceHiroshima UniversityJP¥4.8m2016–2019
A blood-sugar measure fell 16 and 20 mmol/mol with 30 mg and 60 mg daily, versus 4 mmol/mol with placebo over 16 weeks.A blood-sugar measure fell 16 and 20 mmol/mol with 30 mg and 60 mg daily, versus 4 mmol/mol with placebo over 16 weeks.